Regan Whitmer-Johnson Bergmark, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhinitis | 22 | 2023 | 691 | 3.830 |
Why?
|
Sinusitis | 24 | 2023 | 923 | 3.710 |
Why?
|
Otolaryngology | 11 | 2023 | 645 | 2.960 |
Why?
|
Nasal Polyps | 7 | 2023 | 360 | 1.010 |
Why?
|
Insurance Coverage | 7 | 2022 | 1901 | 0.950 |
Why?
|
Head and Neck Neoplasms | 7 | 2024 | 2734 | 0.930 |
Why?
|
Nasal Obstruction | 4 | 2018 | 151 | 0.830 |
Why?
|
Surgical Procedures, Operative | 4 | 2022 | 1876 | 0.800 |
Why?
|
Physicians, Women | 4 | 2021 | 486 | 0.790 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2022 | 454 | 0.750 |
Why?
|
Endolymphatic Sac | 1 | 2020 | 50 | 0.740 |
Why?
|
Specialties, Surgical | 2 | 2022 | 391 | 0.730 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2020 | 90 | 0.710 |
Why?
|
Meniere Disease | 1 | 2020 | 161 | 0.680 |
Why?
|
Otologic Surgical Procedures | 1 | 2020 | 145 | 0.680 |
Why?
|
Hemostasis, Surgical | 1 | 2019 | 128 | 0.680 |
Why?
|
Wound Closure Techniques | 1 | 2019 | 83 | 0.660 |
Why?
|
Emergency Service, Hospital | 6 | 2017 | 7659 | 0.650 |
Why?
|
Turbinates | 1 | 2018 | 68 | 0.620 |
Why?
|
Certification | 1 | 2021 | 424 | 0.610 |
Why?
|
Insurance, Health | 4 | 2020 | 2494 | 0.610 |
Why?
|
Chronic Disease | 19 | 2023 | 9146 | 0.590 |
Why?
|
Publications | 1 | 2019 | 195 | 0.590 |
Why?
|
Authorship | 1 | 2019 | 271 | 0.570 |
Why?
|
Demography | 1 | 2021 | 1656 | 0.550 |
Why?
|
Risk Adjustment | 1 | 2020 | 594 | 0.550 |
Why?
|
Thyroid Diseases | 1 | 2019 | 379 | 0.550 |
Why?
|
Cross-Sectional Studies | 26 | 2023 | 25043 | 0.540 |
Why?
|
Asthma, Aspirin-Induced | 3 | 2023 | 182 | 0.540 |
Why?
|
Healthcare Disparities | 7 | 2022 | 3158 | 0.510 |
Why?
|
Hematoma | 1 | 2019 | 758 | 0.490 |
Why?
|
Social Class | 2 | 2021 | 1999 | 0.490 |
Why?
|
Pneumonia | 2 | 2023 | 2133 | 0.480 |
Why?
|
Automobile Driving | 1 | 2019 | 431 | 0.470 |
Why?
|
Thyroidectomy | 1 | 2019 | 879 | 0.470 |
Why?
|
Internship and Residency | 3 | 2023 | 5788 | 0.460 |
Why?
|
Patient Acceptance of Health Care | 3 | 2023 | 3022 | 0.460 |
Why?
|
Inpatients | 2 | 2023 | 2518 | 0.460 |
Why?
|
Health Services Accessibility | 6 | 2022 | 5137 | 0.450 |
Why?
|
Paranasal Sinuses | 3 | 2020 | 250 | 0.440 |
Why?
|
United States | 32 | 2024 | 69872 | 0.430 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2012 | 50 | 0.420 |
Why?
|
Primary Health Care | 3 | 2017 | 4558 | 0.410 |
Why?
|
Efficiency | 3 | 2020 | 462 | 0.390 |
Why?
|
Humans | 96 | 2024 | 744343 | 0.390 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2011 | 129 | 0.370 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 4034 | 0.360 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3086 | 0.350 |
Why?
|
Air Pollution | 1 | 2023 | 2286 | 0.340 |
Why?
|
Acute Disease | 6 | 2017 | 7149 | 0.340 |
Why?
|
Rheumatic Heart Disease | 1 | 2010 | 177 | 0.340 |
Why?
|
Travel | 2 | 2020 | 788 | 0.340 |
Why?
|
Pharyngitis | 1 | 2010 | 215 | 0.330 |
Why?
|
Cultural Diversity | 2 | 2023 | 359 | 0.330 |
Why?
|
Liposarcoma | 1 | 2012 | 333 | 0.330 |
Why?
|
Pandemics | 10 | 2022 | 8388 | 0.330 |
Why?
|
Vagus Nerve | 1 | 2011 | 438 | 0.330 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1432 | 0.320 |
Why?
|
Medicare | 7 | 2021 | 6566 | 0.310 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.300 |
Why?
|
Asthma | 4 | 2020 | 6011 | 0.300 |
Why?
|
Disease Management | 1 | 2018 | 2459 | 0.300 |
Why?
|
Ambulatory Care | 2 | 2015 | 2708 | 0.300 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 2 | 2020 | 312 | 0.290 |
Why?
|
Endoscopy | 5 | 2020 | 1785 | 0.290 |
Why?
|
General Surgery | 4 | 2022 | 1636 | 0.280 |
Why?
|
Streptococcal Infections | 1 | 2010 | 638 | 0.280 |
Why?
|
Delivery of Health Care | 5 | 2024 | 5319 | 0.270 |
Why?
|
Income | 3 | 2021 | 1913 | 0.270 |
Why?
|
Neurilemmoma | 1 | 2011 | 547 | 0.270 |
Why?
|
Parents | 1 | 2019 | 3407 | 0.260 |
Why?
|
Retrospective Studies | 24 | 2024 | 77449 | 0.260 |
Why?
|
Sleep | 1 | 2021 | 4623 | 0.260 |
Why?
|
Female | 48 | 2024 | 380194 | 0.260 |
Why?
|
Male | 46 | 2024 | 350118 | 0.260 |
Why?
|
Socioeconomic Factors | 8 | 2022 | 7785 | 0.260 |
Why?
|
Morbidity | 2 | 2020 | 1769 | 0.250 |
Why?
|
Health Services | 2 | 2016 | 758 | 0.250 |
Why?
|
Anti-Bacterial Agents | 4 | 2018 | 7181 | 0.250 |
Why?
|
Office Visits | 2 | 2022 | 598 | 0.240 |
Why?
|
Qualitative Research | 5 | 2024 | 2682 | 0.240 |
Why?
|
Poverty | 3 | 2021 | 2660 | 0.220 |
Why?
|
Adult | 29 | 2023 | 214055 | 0.220 |
Why?
|
Attitude of Health Personnel | 2 | 2022 | 3843 | 0.220 |
Why?
|
Organizations | 1 | 2024 | 170 | 0.220 |
Why?
|
Physicians | 1 | 2020 | 4567 | 0.210 |
Why?
|
Emigrants and Immigrants | 1 | 2008 | 522 | 0.210 |
Why?
|
Cell Adhesion Molecules | 2 | 2019 | 1602 | 0.210 |
Why?
|
Middle Aged | 31 | 2024 | 213383 | 0.200 |
Why?
|
Sex Factors | 6 | 2021 | 10397 | 0.200 |
Why?
|
Faculty, Medical | 2 | 2021 | 1181 | 0.200 |
Why?
|
Length of Stay | 4 | 2023 | 6309 | 0.190 |
Why?
|
Medicaid | 5 | 2021 | 2736 | 0.190 |
Why?
|
Physical Examination | 2 | 2019 | 1237 | 0.190 |
Why?
|
Medical Staff | 1 | 2021 | 43 | 0.190 |
Why?
|
Granuloma, Plasma Cell | 1 | 2021 | 84 | 0.190 |
Why?
|
Climate Change | 2 | 2023 | 418 | 0.190 |
Why?
|
Educational Status | 2 | 2021 | 2540 | 0.180 |
Why?
|
Fee Schedules | 1 | 2020 | 86 | 0.180 |
Why?
|
Gentamicins | 1 | 2020 | 255 | 0.180 |
Why?
|
Free Tissue Flaps | 1 | 2024 | 328 | 0.170 |
Why?
|
Specialty Boards | 1 | 2021 | 227 | 0.170 |
Why?
|
Gross Domestic Product | 1 | 2019 | 77 | 0.170 |
Why?
|
Unemployment | 1 | 2021 | 214 | 0.170 |
Why?
|
Ibuprofen | 1 | 2021 | 236 | 0.170 |
Why?
|
Diverticulitis | 1 | 2021 | 171 | 0.170 |
Why?
|
Infant Care | 1 | 2020 | 183 | 0.170 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2021 | 286 | 0.170 |
Why?
|
Heart Failure | 1 | 2023 | 10900 | 0.170 |
Why?
|
Geography | 1 | 2021 | 669 | 0.160 |
Why?
|
Anesthetics, Inhalation | 1 | 2023 | 570 | 0.160 |
Why?
|
Mucociliary Clearance | 1 | 2018 | 67 | 0.160 |
Why?
|
Tonsillectomy | 1 | 2021 | 255 | 0.160 |
Why?
|
Aspirin | 4 | 2023 | 3282 | 0.160 |
Why?
|
Health Care Costs | 2 | 2022 | 3209 | 0.160 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.150 |
Why?
|
Cosmetic Techniques | 1 | 2019 | 135 | 0.150 |
Why?
|
Facial Transplantation | 1 | 2020 | 226 | 0.150 |
Why?
|
Absenteeism | 1 | 2018 | 250 | 0.150 |
Why?
|
Emergency Treatment | 1 | 2021 | 517 | 0.140 |
Why?
|
Dental Care | 1 | 2019 | 262 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 397 | 0.140 |
Why?
|
Epistaxis | 1 | 2017 | 111 | 0.140 |
Why?
|
Rhinoplasty | 1 | 2020 | 226 | 0.140 |
Why?
|
Hypertrophy | 1 | 2018 | 569 | 0.140 |
Why?
|
Hemostatic Techniques | 1 | 2017 | 116 | 0.140 |
Why?
|
Academic Medical Centers | 2 | 2024 | 2759 | 0.140 |
Why?
|
Health Services Research | 2 | 2022 | 1836 | 0.140 |
Why?
|
Career Mobility | 1 | 2018 | 262 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3923 | 0.130 |
Why?
|
Bibliometrics | 1 | 2019 | 339 | 0.130 |
Why?
|
Craniotomy | 1 | 2020 | 729 | 0.130 |
Why?
|
Facial Pain | 1 | 2016 | 127 | 0.130 |
Why?
|
SEER Program | 1 | 2020 | 1508 | 0.130 |
Why?
|
Medically Uninsured | 1 | 2021 | 853 | 0.130 |
Why?
|
Patients | 1 | 2022 | 900 | 0.130 |
Why?
|
Neck | 1 | 2019 | 697 | 0.130 |
Why?
|
Maternal Health Services | 1 | 2020 | 455 | 0.130 |
Why?
|
Odds Ratio | 3 | 2018 | 9849 | 0.130 |
Why?
|
Reimbursement, Incentive | 1 | 2020 | 540 | 0.130 |
Why?
|
Burnout, Professional | 1 | 2024 | 694 | 0.130 |
Why?
|
Neoplasms | 1 | 2024 | 21683 | 0.120 |
Why?
|
Health Resources | 1 | 2021 | 911 | 0.120 |
Why?
|
Attitude | 1 | 2019 | 776 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 550 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2020 | 670 | 0.120 |
Why?
|
Mouth Neoplasms | 1 | 2019 | 601 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2023 | 1102 | 0.120 |
Why?
|
Risk-Taking | 1 | 2019 | 986 | 0.120 |
Why?
|
Accidents, Traffic | 1 | 2019 | 819 | 0.110 |
Why?
|
Quality of Life | 7 | 2024 | 12804 | 0.110 |
Why?
|
Postoperative Care | 1 | 2020 | 1486 | 0.110 |
Why?
|
Nasal Septum | 1 | 2014 | 127 | 0.110 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 642 | 0.110 |
Why?
|
Mexico | 2 | 2021 | 690 | 0.110 |
Why?
|
Reoperation | 2 | 2020 | 4201 | 0.110 |
Why?
|
Health Personnel | 2 | 2023 | 3218 | 0.110 |
Why?
|
Interleukin-5 | 2 | 2023 | 273 | 0.110 |
Why?
|
Biomedical Research | 2 | 2019 | 3309 | 0.110 |
Why?
|
Surgery, Plastic | 1 | 2019 | 624 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 2017 | 536 | 0.110 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.110 |
Why?
|
Occupational Diseases | 1 | 2021 | 1471 | 0.110 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2016 | 300 | 0.110 |
Why?
|
Pain, Postoperative | 2 | 2021 | 1643 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 2 | 2018 | 1855 | 0.100 |
Why?
|
Language | 1 | 2021 | 1471 | 0.100 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2418 | 0.100 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2016 | 709 | 0.100 |
Why?
|
Anesthesiology | 1 | 2022 | 1060 | 0.100 |
Why?
|
Meningioma | 1 | 2020 | 1209 | 0.100 |
Why?
|
Malaria, Cerebral | 1 | 2012 | 135 | 0.100 |
Why?
|
Aged | 18 | 2024 | 163280 | 0.100 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11031 | 0.100 |
Why?
|
Skilled Nursing Facilities | 1 | 2015 | 372 | 0.100 |
Why?
|
Health Surveys | 2 | 2021 | 4037 | 0.100 |
Why?
|
Health Care Surveys | 2 | 2016 | 2453 | 0.100 |
Why?
|
Interleukin-13 | 2 | 2023 | 389 | 0.100 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2011 | 109 | 0.090 |
Why?
|
Drainage | 1 | 2016 | 1142 | 0.090 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2021 | 1209 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2291 | 0.090 |
Why?
|
Adolescent | 5 | 2023 | 85781 | 0.090 |
Why?
|
Anesthesia | 1 | 2022 | 1561 | 0.090 |
Why?
|
Forecasting | 1 | 2019 | 2951 | 0.090 |
Why?
|
Child, Preschool | 4 | 2021 | 41006 | 0.090 |
Why?
|
Leadership | 1 | 2019 | 1357 | 0.090 |
Why?
|
Patient Readmission | 2 | 2021 | 3114 | 0.090 |
Why?
|
Child | 6 | 2021 | 77709 | 0.090 |
Why?
|
Prognosis | 4 | 2024 | 29063 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1637 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2023 | 5317 | 0.080 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11124 | 0.080 |
Why?
|
Scalp | 1 | 2011 | 380 | 0.080 |
Why?
|
Comorbidity | 2 | 2020 | 10388 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2021 | 15295 | 0.080 |
Why?
|
Mass Screening | 1 | 2024 | 5255 | 0.080 |
Why?
|
Prospective Studies | 8 | 2021 | 53288 | 0.080 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 1049 | 0.080 |
Why?
|
Young Adult | 4 | 2019 | 56430 | 0.080 |
Why?
|
Age Factors | 2 | 2021 | 18370 | 0.070 |
Why?
|
Depression | 2 | 2017 | 7766 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12788 | 0.070 |
Why?
|
Risk Factors | 8 | 2021 | 72290 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3420 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15540 | 0.070 |
Why?
|
Tanzania | 1 | 2010 | 1346 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12245 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2020 | 63114 | 0.070 |
Why?
|
Stress, Psychological | 1 | 2021 | 4245 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3749 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2017 | 2071 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4468 | 0.060 |
Why?
|
California | 1 | 2008 | 1402 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2016 | 5686 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
Malaria, Falciparum | 1 | 2012 | 1077 | 0.060 |
Why?
|
Steam | 1 | 2023 | 31 | 0.060 |
Why?
|
Greenhouse Effect | 1 | 2023 | 26 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2022 | 3133 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 9959 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2012 | 2132 | 0.060 |
Why?
|
Antibody-Producing Cells | 1 | 2023 | 143 | 0.060 |
Why?
|
Developing Countries | 1 | 2016 | 2815 | 0.060 |
Why?
|
Health Status | 1 | 2016 | 4034 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2012 | 1580 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1790 | 0.050 |
Why?
|
Cohort Studies | 2 | 2024 | 40561 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3674 | 0.050 |
Why?
|
Health Expenditures | 1 | 2015 | 2348 | 0.050 |
Why?
|
Computer Literacy | 1 | 2022 | 43 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19905 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2008 | 2539 | 0.050 |
Why?
|
Logistic Models | 3 | 2022 | 13408 | 0.050 |
Why?
|
Cuba | 1 | 2021 | 47 | 0.050 |
Why?
|
Salaries and Fringe Benefits | 1 | 2024 | 264 | 0.050 |
Why?
|
Central America | 1 | 2021 | 68 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2023 | 473 | 0.050 |
Why?
|
South America | 1 | 2021 | 181 | 0.050 |
Why?
|
New Jersey | 1 | 2021 | 290 | 0.050 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.050 |
Why?
|
Relative Value Scales | 1 | 2020 | 84 | 0.050 |
Why?
|
Puerto Rico | 1 | 2021 | 356 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12959 | 0.040 |
Why?
|
Adenoidectomy | 1 | 2021 | 159 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2023 | 1150 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2023 | 1147 | 0.040 |
Why?
|
Nasopharynx | 1 | 2021 | 379 | 0.040 |
Why?
|
Self Report | 2 | 2021 | 3558 | 0.040 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2021 | 234 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 846 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 291 | 0.040 |
Why?
|
New York City | 1 | 2021 | 710 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 617 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5510 | 0.040 |
Why?
|
Sneezing | 1 | 2016 | 17 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2021 | 413 | 0.040 |
Why?
|
Gadolinium | 1 | 2021 | 952 | 0.040 |
Why?
|
Colectomy | 1 | 2021 | 683 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3396 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 734 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 687 | 0.030 |
Why?
|
Pakistan | 1 | 2016 | 295 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1534 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 571 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 687 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 933 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1774 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2021 | 2016 | 0.030 |
Why?
|
Perception | 1 | 2019 | 1198 | 0.030 |
Why?
|
Breast | 1 | 2021 | 1969 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1660 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4776 | 0.030 |
Why?
|
Disabled Persons | 1 | 2021 | 1212 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1241 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3703 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2023 | 3690 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5952 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 25625 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2585 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3870 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2012 | 629 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2022 | 3610 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2012 | 1105 | 0.020 |
Why?
|
India | 1 | 2016 | 2197 | 0.020 |
Why?
|
Phenotype | 2 | 2017 | 16365 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29144 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8663 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2603 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3313 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5300 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7322 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.020 |
Why?
|
Uganda | 1 | 2012 | 1243 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1411 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10481 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3019 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3966 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12354 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7729 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3474 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57776 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14722 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23403 | 0.010 |
Why?
|
Biopsy | 1 | 2011 | 6756 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35136 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81183 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168757 | 0.010 |
Why?
|